JF Rooney, SE Straus, ML Mannix, CR … - Annals of internal medicine, 1993 - Am Coll Physicians Objective: To determine whether oral acyclovir reduces the incidence of
recurrent herpes labialis in otherwise healthy patients with proven frequently
recurrent disease. ... Design: Randomized, double-blind, ... Cited by 93 - Related articles - BL Direct - All 4 versions
SL Spruance, ML Hamill, WS Hoge, LG Davis, … - JAMA: the journal of the American Medical Association, 1988 - ncbi.nlm.nih.gov To determine the effectiveness of an antiviral to prevent herpes labialis during
a brief, high-risk circumstance, 147 persons with a history of sun-induced
recurrences were treated prophylactically with oral acyclovir or matching ... Cited by 85 - Related articles - All 3 versions
SL Spruance, NH Rowe, GW Raborn, EA … - The Journal of infectious diseases, 1999 - UChicago Press Featured in US News & World Report "Common Cold Virus Alters Body's Genes"
October 24, 2008 Comparison of the Safety and Immunogenicity of 2 Respiratory
Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine ... Cited by 58 - Related articles - BL Direct - All 5 versions
SL Spruance, JCB Stewart, NH Rowe, MB … - The Journal of Infectious Diseases, 1990 - jstor.org Treatment of Recurrent Herpes Simplex Labialis with Oral Acyclovir ...
Spotswood L. Spruance, Jeffery CB Stewart, Nathaniel H. Rowe, Mark B. McKeough,
Gay Wenerstrom, and Donna J. Freeman ... From the Division of Infectious ... Cited by 117 - Related articles - All 3 versions
R Boon, JJ Goodman, J Martinez, GL Marks, … - Clinical therapeutics, 2000 - Elsevier Healthy male and female patients (mean age, 38.3 years; range, 18 to 81 years)
who had a history of sunlight-induced herpes labialis (mean of 6 recurrences in
previous 12 months) applied either penciclovir cream (n = 266) or purified ... Cited by 44 - Related articles - BL Direct - All 4 versions
SL Spruance, TL Rea, C Thoming, R Tucker, … - Jama, 1997 - Am Med Assoc OBJECTIVE: To compare the safety and efficacy of topical 1% penciclovir cream
with vehicle control cream (placebo) for the treatment of a recurrent episode of
herpes simplex labialis (cold sores) in immunocompetent patients. DESIGN: ... Cited by 153 - Related articles - BL Direct - All 3 versions
- ►nih.gov SL Spruance, TM Jones, MM Blatter, M Vargas- … - Antimicrobial agents and chemotherapy, 2003 - Am Soc Microbiol Oral valacyclovir is better absorbed than oral acyclovir, increasing acyclovir
bioavailability three- to fivefold. This provides the opportunity to explore
whether high systemic acyclovir concentrations are effective in the ... Cited by 71 - Related articles - BL Direct - All 7 versions
- ►bmj.com J Amir, L Harel, Z Smetana, I Varsano - British Medical Journal, 1997 - bmj.com You are seeing this message because your web browser does not support basic web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Objectives: To examine ... Cited by 83 - Related articles - BL Direct - All 5 versions
GW Raborn, WT McGaw, M Grace, LD Tyrrell … - The Journal of the American Dental Association, 1987 - adajournal.com A study of the effects of oral acyclovir (200 mg), administered five times per
day for 5 days in 210 patients who cultured positive for herpes labialis, is
made. A total of 149 patients were followed through three episodes each of ... Cited by 66 - Related articles - All 9 versions
D BAKER, D EISEN - Cutis(New York, NY), 2003 - cat.inist.fr The oral antiviral valacyclovir, which is 3 to 5 times more bioavailable than
its parent compound acyclovir, is a good candidate for effective therapy to
suppress recurrent herpes labialis lesions. The efficacy of oral ... Cited by 30 - Related articles - BL Direct - All 2 versions
